8-K: Verano Holdings Reports Mixed Q3 2024 Results Amidst Market Shifts

Verano Holdings Corp. announced its third quarter 2024 financial results, showing a decrease in revenue and a net loss, but with positive adjusted EBITDA.

Summary

• Verano Holdings reported a net revenue of $217 million for the third quarter of 2024, which is a decrease compared to both the previous quarter ($222 million) and the same quarter last year ($240 million).
• The company's gross profit was $109 million, representing 50% of revenue, down from 55% in the third quarter of 2023.
• SG&A expenses increased to $92 million, or 43% of revenue, due to increased headcount related to new store openings.
• Verano experienced a net loss of $43 million, or 20% of revenue, which is a larger loss compared to the $18 million loss in the same quarter of the previous year.
• Adjusted EBITDA was $64 million, or 30% of revenue.
• Net cash provided by operating activities was $30 million for the quarter and $69 million year-to-date, down from $77 million in the prior year period.
• Capital expenditures were $57 million for the quarter and $85 million year-to-date, up from $27 million in the prior year period.
• The company expects organic trends similar to the third quarter to continue into the fourth quarter of 2024.

Sentiment

Score: 4

Explanation: The document presents mixed results with a significant net loss and declining revenue, offset by positive adjusted EBITDA and expansion efforts. The overall tone is cautiously optimistic, but the financial performance raises concerns.

Positives

• Adjusted EBITDA was $64 million, or 30% of revenue, indicating profitability before certain expenses.
• The company expanded its retail footprint by opening new dispensaries in key markets.
• Verano launched the Cabbage Club membership program, which could drive customer loyalty.
• The company completed strategic acquisitions in Arizona and Virginia, strengthening its market position.
• Verano commenced adult use sales in Ohio and Connecticut, expanding its customer base.

Negatives

• Revenue decreased to $217 million, down from $240 million in the same quarter last year.
• Gross profit decreased to $109 million, or 50% of revenue, down from 55% in the same quarter last year.
• The company reported a net loss of $43 million, a significant increase from the $18 million loss in the same quarter last year.
• SG&A expenses increased to $92 million, or 43% of revenue, due to increased headcount.
• Net cash provided by operating activities decreased to $30 million for the quarter.

Risks

• The decrease in revenue was driven by declines in Florida retail due to a temporary shift in cultivation output, as well as expected declines in Illinois and New Jersey retail due to increased competition.
• The increase in SG&A expenses due to increased headcount could impact profitability if not managed effectively.
• The company has a working capital deficit of $114 million and total debt of $420 million, which could pose financial risks.
• The cannabis industry is subject to regulatory changes, which could impact the company's operations and financial performance.
• The company's future performance is subject to the success of its expansion plans and the overall market conditions.

Future Outlook

The company expects organic trends similar to those seen in the third quarter 2024 to continue into the fourth quarter 2024. They also plan additional dispensary openings and are looking forward to potential catalysts at the state and federal levels, including rescheduling proceedings and tax relief.

Management Comments

• George Archos, Verano founder, Chairman and Chief Executive Officer, noted that cannabis took center stage as a key bipartisan issue during the election season.
• Archos expressed optimism about growth prospects in Florida despite the Amendment 3 outcome.
• Archos stated that the company is prepared to leverage potential catalysts in the months and years ahead, including rescheduling proceedings and working with the new administration.

Industry Context

The announcement comes at a time when the cannabis industry is experiencing increased competition and regulatory changes. The company's performance is being impacted by market shifts in key states like Florida, Illinois, and New Jersey. The comments about rescheduling and potential federal reforms reflect the broader industry's focus on regulatory changes that could significantly impact operations and profitability.

Comparison to Industry Standards

• Verano's revenue decline of 2.6% quarter-over-quarter is concerning, as many MSOs are showing growth or stability in revenue. For example, Curaleaf reported a 1.5% increase in revenue in their most recent quarter, while Trulieve saw a 10% increase.
• The gross profit margin of 50% is below the industry average, with companies like Green Thumb Industries reporting gross margins closer to 55%.
• The net loss of $43 million is significant and highlights the challenges Verano is facing in managing costs and achieving profitability. Other MSOs like Cresco Labs have shown better control over losses.
• Verano's adjusted EBITDA margin of 30% is competitive, but companies like Trulieve have reported higher margins, indicating better operational efficiency.
• The increase in SG&A expenses to 43% of revenue is a concern, as it suggests that the company is not effectively managing its operating costs compared to peers like Ayr Wellness, which has focused on cost control.

Stakeholder Impact

• Shareholders may be concerned about the net loss and declining revenue.
• Employees may be impacted by the company's cost management efforts.
• Customers may benefit from the expansion of retail locations and the Cabbage Club membership program.
• Suppliers may be affected by changes in the company's production and procurement strategies.
• Creditors may be concerned about the company's working capital deficit and debt levels.

Next Steps

• The company plans additional dispensary openings across multiple markets.
• Verano intends to leverage potential catalysts at the state and federal levels, including rescheduling proceedings.
• The company will continue to monitor and adapt to market conditions and regulatory changes.

Key Dates

Keywords

cannabis, marijuana, multi-state operator, MSO, financial results, revenue, EBITDA, net loss, dispensaries, retail, wholesale, Cabbage Club, acquisitions, expansion